Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk
Open Access
- 11 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 30 (29), 3295-3304
- https://doi.org/10.1038/onc.2011.81
Abstract
SWI/SNF (SWItch/sucrose non-fermentable) complexes are ATP-dependent chromatin remodeling enzymes critically involved in the regulation of multiple functions, including gene expression, differentiation, development, DNA repair, cell adhesion and cell cycle control. BRM, a key SWI/SNF complex subunit, is silenced in 15–20% of many solid tumors. As BRM-deficient mice develop 10-fold more tumors when exposed to carcinogens, BRM is a strong candidate for a cancer susceptibility gene. In this paper, we show that BRM is regulated by transcription, thus demonstrating that the promoter region is important for BRM expression. We sequenced the BRM promoter region, finding two novel promoter indel polymorphisms, BRM −741 and BRM −1321, that are in linkage disequilibrium (D′⩾0.83). The variant insertion alleles of both polymorphisms produce sequence variants that are highly homologous to myocyte enhancer factor-2 (MEF2) transcription factor-binding sites; MEF2 is known to recruit histone deacetylases that silence BRM expression. Each polymorphic BRM insertion variant is found in ∼20% of Caucasians, and each correlates strongly with the loss of protein expression of BRM, both in cancer cell lines (P=0.009) and in primary human lung tumor specimens (P=0.015). With such strong functional evidence, we conducted a case–control study of 1199 smokers. We found an increased risk of lung cancer when both BRM homozygous promoter insertion variants were present: adjusted odds ratio of 2.19 (95% confidence interval, 1.40–3.43). Thus, we here demonstrate a strong functional association between these polymorphisms and loss of BRM expression. These polymorphisms thus have the potential to identify a sub-population of smokers at greater lung cancer risk, wherein this risk could be driven by an aberrant SWI/SNF chromatin-remodeling pathway.Keywords
This publication has 53 references indexed in Scilit:
- Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategyOncogene, 2011
- BRG1 mutations found in human cancer cell lines inactivate Rb‐mediated cell‐cycle arrestJournal of Cellular Physiology, 2010
- Replication of Lung Cancer Susceptibility Loci at Chromosomes 15q25, 5p15, and 6p21: A Pooled Analysis From the International Lung Cancer ConsortiumJNCI Journal of the National Cancer Institute, 2010
- A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for AdenocarcinomaAmerican Journal of Human Genetics, 2009
- The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cellsOncogene, 2009
- The SWI/SNF complex and cancerOncogene, 2009
- Environment And Genetics in Lung cancer Etiology (EAGLE) study: An integrative population-based case-control study of lung cancerBMC Public Health, 2008
- Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2Molecular and Cellular Biology, 2007
- Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting γ-H2AX inductionThe EMBO Journal, 2006
- Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignanciesJournal of Cellular Physiology, 2000